Explore
Validate
LearnHPA001812
antibody from Atlas Antibodies
Targeting: APOBEC3G
bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001812 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001812, RRID:AB_1078175
- Product name
- Anti-APOBEC3G
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human APOBEC3G, Gene description: apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, Alternative Gene Names: bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019, Validated applications: IHC, Uniprot ID: Q9HC16, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma.
Defining early SIV replication and dissemination dynamics following vaginal transmission
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.
Immune clearance of highly pathogenic SIV infection
Peng T, Liu B, Lin S, Cao C, Wu P, Zhi W, Wei Y, Chu T, Gui L, Ding W
Heliyon 2022 Dec;8(12):e12191
Heliyon 2022 Dec;8(12):e12191
Defining early SIV replication and dissemination dynamics following vaginal transmission
Deleage C, Immonen T, Fennessey C, Reynaldi A, Reid C, Newman L, Lipkey L, Schlub T, Camus C, O’Brien S, Smedley J, Conway J, Del Prete G, Davenport M, Lifson J, Estes J, Keele B
Science Advances 2019;5(5)
Science Advances 2019;5(5)
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma
Leonard B, Starrett G, Maurer M, Oberg A, Van Bockstal M, Van Dorpe J, De Wever O, Helleman J, Sieuwerts A, Berns E, Martens J, Anderson B, Brown W, Kalli K, Kaufmann S, Harris R
Clinical Cancer Research 2016;22(18):4746-4755
Clinical Cancer Research 2016;22(18):4746-4755
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.
Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, Contijoch E, Todd JP, Silvestri G, Nason M, Norgren RB Jr, Keele BF, Rao S, Langer JA, Lifson JD, Schreiber G, Douek DC
Nature 2014 Jul 31;511(7511):601-5
Nature 2014 Jul 31;511(7511):601-5
Immune clearance of highly pathogenic SIV infection
Hansen S, Jr M, Ventura A, Hughes C, Gilbride R, Ford J, Oswald K, Shoemaker R, Li Y, Lewis M, Gilliam A, Xu G, Whizin N, Burwitz B, Planer S, Turner J, Legasse A, Axthelm M, Nelson J, Früh K, Sacha J, Estes J, Keele B, Edlefsen P, Lifson J, Picker L
Nature 2013;502(7469):100-104
Nature 2013;502(7469):100-104
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human lymph node and pancreas tissues using HPA001812 antibody. Corresponding APOBEC3G RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
